Single-chain antibodies against human insulin-like growth factor I receptor: Expression, purification, and effect on tumor growth

Cancer Immunology Immunotherapy

Volumn 49, Issue 4-5, 2000, Pages 243-252

  Li, Shu Lian ^a   Liang, Shu Jian ^a   Guo, Ning ^a   Wu, Anna M ^a   Fujita Yamaguchi, Yoko ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

IGF; Recombinant antibody; Single chain antibody; Tumor growth inhibition

Indexed keywords

RECEPTOR ANTIBODY; RECOMBINANT ANTIBODY; SOMATOMEDIN RECEPTOR;

ANIMAL CELL; ANTIBODY DETECTION; ARTICLE; CANCER INHIBITION; CELL STRAIN MCF 7; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; MYELOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION;

EID: 0033929947     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620000115     Document Type: Article

References (45)

1. Arteaga CL, Osborne CK (1989) Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor. Cancer Res 49: 6237
2. Arteaga CL, Kitten L-J, Coronado EB, Jacobs S, Kull FC Jr, Allred DC, Osborne CK (1989) Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J Clin Invest 84: 1418
3. Baserga R, Hongo A, Rubini M, Prisco M, Valentinis B (1997) The IGF-I receptor in cell growth, transformation and apoptosis. Biochim Biophys Acta 1332: F105
4. Bebbington CR, Renner G, Thomson S, King D, Abrams D, Yarranton GT (1992) High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker. Biotechnology 10: 169
5. Beerli RR, Wels W, Hynes NE (1994) Autocrine inhibition of the epidermal growth factor receptor by intracellular expression of a single-chain antibody. Biochem Biophys Res Commun 204: 666
6. Beerli RR, Wels W, Hynes NE (1994) Intracellular expression of single chain antibodies reverts ErbB-2 transformation. J Biol Chem 269: 23 931
7. Coppola D, Ferber A, Miura M, Sell C, D'Ambrosio C, Rubin R, Baserga R (1994) A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol Cell Biol 14: 4588
8. Damon SE, Maddison L, Ware JL, Plymate SR (1998) Overexpression of an inhibitory insulin-like growth factor binding protein (IGFBP), IGFBP-4, delays onset of prostate tumor formation. Endocrinology 139: 3456
9. Dunn SE, Hardman RA, Kari FW, Barrett JC (1997) Insulin-like growth factor 1 (IGF-1) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs. Cancer Res 57: 2687
10. Furlanetto RW, Harwell SE, Baggs RB (1993) Effects of insulin-like growth factor receptor inhibition on human melanomas in culture and in athymic mice. Cancer Res 53: 2522
11. Guvakova MA, Surmacz E (1997) Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells. Cancer Res 57: 2606
12. Hieter PA, Max EE, Seidman JG, Maizel JV Jr, Leder P (1980) Cloned human and mouse kappa immunoglobulin constant and J region genes conserve homology in functional segments. Cell 22: 197
13. Honjo T, Obata M, Yamawaki-Kataoka Y, Kataoka T, Kawakami T, Takahashi N, Mano Y (1979) Cloning and complete nucleotide sequence of mouse immunoglobulin gamma 1 chain gene. Cell 18: 559
14. Hu S, Shively L, Raubitschek AA, Sherman M, Williams L, Wong JYC, Shively JE, Wu AM (1996) Minibody: a novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts. Cancer Res 56: 3055
15. Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C (1991) Sequences of proteins of immunological interest, 15th edn. US Department of Health and Human Services, NIH, Bethesda, Md
16. Kaleko M, Rutter WJ, Miller AD (1990) Overexpression of the human insulin-like growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol Cell Biol 10: 464
17. Kimura G, Kasuya J, Giannini S, Honda Y, Mohan S, Kawachi MH, Akimoto M, Fujita-Yamaguchi Y (1996) Insulin-like growth factor (IGF) system components in human prostate cancer cell lines, LNCaP, DU145 and PC-3. Int J Urol 3: 39
18. LeBon TR, Jacobs S, Cuatrecasas P, Kathuria S, Fujita-Yamaguchi Y (1986) Purification of insulin-like growth factor I receptor from human placental membranes. J Biol Chem 261: 7685
19. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr (1995) Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocrine Rev 16: 143
20. Li SL, Kato J, Paz IB, Kasuya J, Fujita-Yamaguchi Y (1993) Two new monoclonal antibodies against the alpha subunit of the human insulin-like growth factor-I receptor. Biochem Biophys Res Commun 196: 92
21. Li SL, Goko H, Xu ZD, Kimura G, Sun Y, Kawachi MH, Wilson TG, Wilczynski S, Fujita-Yamaguchi Y (1998) Expression of insulin-like growth factor (IGF)-II in human prostate, breast, bladder, and paraganglioma tumors. Cell Tissue Res 291: 469
22. Li SL, Termini J, Hayward A, Siddle K, Zick Y, Koval A, LeRoith D, Fujita-Yamaguchi Y (1998) The carboxyl-terminal domain of insulin-like growth factor-I receptor interacts with the insulin receptor and activates its protein tyrosine kinase. FEBS Lett 421: 45
23. Neuenschwander S, Roberts CT Jr, LeRoith D (1995) Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth factor I receptor antisense ribonucleic acid. Endocrinology 136: 4298
24. Neumaier M, Shively L, Chen FS, Gaida FJ, Ilgen C, Paxton RJ, Shively JE, Riggs AD (1990) Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/ mouse T84.66 genes in myeloma and Chinese hamster ovary cells. Cancer Res 50: 2128
25. Osborne CK, Coronado EB, Kitten LJ, Arteaga CI, Fuqua SA, Ramasharma K, Marshall M, Li CH (1989) Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. Mol Endocrinol 3: 1701
26. O'Shannessy DJ, Brigham-Burke M, Soneson KK, Hensley P, Brooks I (1994) Determination of rate and equilibrium binding constants for macromolecular interactions by surface plasmon resonance. Methods Enzymol 240: 323
27. Papa V, Gliozzo B, Clark GM, McGuire WL, Moore D, Fujita-Yamaguchi Y, Vigneri R, Goldfine ID, Pezzino V (1993) Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer. Cancer Res 53: 3736
28. Pezzino V, Milazzo G, Frittitta L, Vigneri R, Ezaki O, Kasahara M, Le Bon TR, Goldfine ID, Fujita-Yamaguchi Y (1991) Radioimmunoassay for human insulin-like growth factor-I receptor: Applicability to breast carcinoma specimens and cell lines. Metabolism 40: 861
29. Prager D, Li HL, Asa S, Melmed S (1994) Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant. Proc Natl Acad Sci USA 91: 2181
30. Resnicoff M, Coppola D, Sell C, Rubin R, Ferrone S, Baserga R (1994) Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res 54: 4848
31. Resnik JL, Reichart DB, Huey K, Webster NJ, Seely BL (1998) Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer. Cancer Res 58: 1159
32. Sakano K, Enjoh T, Numata F, Fujiwara H, Marumoto Y, Higashihashi N, Sato Y, Perdue JF, Fujita-Yamaguchi Y (1992) The design, expression, and characterization of human insulin-like growth factor II mutants specific for either the IGF-II/cation independent mannose 6-phosphate receptor or IGF-I receptor. J Biol Chem 266: 20 626
33. Schmidt M, Maurer-Gebhard M, Groner B, Koehler G, Brochmann-Santos G, Wels W (1999) Suppression of metastasis formation by a recombinant single chain antibody-toxin targeted to full-length and oncogenic variant EGF receptors. Oncogene 18: 1711
34. Sell C, Dumenil G, Deveaud C, Miura M, Coppola D, DeAngelis T, Rubin R, Efstratiadis A, Baserga R (1994) Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol Cell Biol 14: 3604
35. Skrepnik N, Zieske AW, Bravo JC, Gillespie AT, Hunt JD (1999) Recombinant oncotoxin AR209 (anti-P185 erbB-2) diminishes human prostate carcinoma xenografts. J Urol 161: 984
36. Trojan J, Blossey BK, Johnson TR, Rudin SD, Tykocinski M, Ilan J (1992) Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I. Proc Natl Acad Sci USA 89: 4874
37. Turner BC, Haffty BG, Narayanan L, Yuan J, Havre PA, Gumbs AA, Kaplan L, Burgaud JL, Carter D, Baserga R, Glazer PM (1997) Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res 57: 3079
38. Ullrich MJ, Ley TJ (1990) Function of normal and mutated gamma-globin gene promoters in electroporated K562 erythroleukemia cells. Blood 75: 990
39. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, LeBon TR, Kathuria S, Chen E, Jacobs S, Franke U, Ramachandran J, Fujita-Yamaguchi Y (1986) Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 5: 2503
40. Wu AM, Chen W, Raubitschek A, Williams LE, Neumaier M, Fischer R, Hu SZ, Odom-Maryon T, Wong Y, Shively JE (1996) Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers. Immunotechnology 2: 21
41. Xiong L, Kasuya J, Li SL, Kato J, Fujita-Yamaguchi Y (1992) Growth-stimulatory monoclonal antibodies against human insulin-like growth factor I receptor. Proc Natl Acad Sci USA 89: 5356
42. Xu QY, Paxton RJ, Fujita-Yamaguchi Y (1990) Substructural analysis of the insulin receptor by microsequence analyses of limited tryptic fragments isolated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis in the absence or presence of dithiothreitol. J Biol Chem 265: 18 673
43. Xu QY, Li SL, LeBon TR, Fujita-Yamaguchi Y (1991) Aggregation of IGF-I receptors or insulin receptors and activation of their kinase activity are simultaneously caused by the presence of polycations or K-ras basic peptides. Biochemistry 30: 11 811
44. Xu ZD, Oey L, Mohan S, Kawachi MH, Lee NS, Rossi JJ, Fujita-Yamaguchi Y (1999) Hammerhead ribozyme-mediated cleavage of the human insulin-like growth factor-II ribonucleic acid in vitro and in prostate cancer cells. Endocrinology 140: 2134
45. Yates JR 3rd, Eng JK, McCormack AL, Schieltz D (1995) Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal Chem 67: 1426